It is possible that the main title of the report Chronic Lymphocytic Leukemia is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.
Revised text to state that while these results are promising, there were problems, including the following: the results varied in different publications; the comparison group was not actively followed; the confidence interval was near 1.0; intention-to-treat analysis was not used; assessment of outcome was not blinded; and generalizability to other populations is uncertain (cited Aghoram et al. as reference 14).
Added text about a review that concluded the method of measuring alpha-fetoprotein was not sensitive enough to detect hepatocellular carcinoma, affecting the interpretation of negative results.
This summary is written and maintained by the PDQ Screening and Prevention Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ NCI's Comprehensive Cancer Database pages.
In this article
This information is produced and provided by the National
Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National
Institute via the Internet web site at http://
.gov or call 1-800-4-CANCER.
WebMD Public Information from the National Cancer Institute
September 04, 2014
This information is not intended to replace the advice of a doctor.
Healthwise disclaims any liability for the decisions you make based on this